AC Immune SA (ACIU) CHF0.02

Sell:$2.57Buy:$3.37Price decreased$0.02 (0.47%)

NASDAQ:Price increased1.60%
Market closed |
Prices delayed by at least 15 minutes
Sell:$2.57
Buy:$3.37
Change:Price decreased$0.02 (0.47%)
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:$2.57
Buy:$3.37
Change:Price decreased$0.02 (0.47%)
Market closed |
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$3.10
Previous close$3.19
Market cap$335.85m
P/E ratio-99999.99
Volume76,318
Dividend yield0.00%
EMS-

Company information

AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as ...

  • LocationSwitzerland
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue112.67m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Balance sheet 2025

Total assetsCHF 154.25m
Total liabilitiesCHF 109.37m
Net debt-CHF 86.87m

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.